Recently, one of our Partners, Joe Magliocco, took part in a roundtable discussion hosted by Greater Zurich Area (GZA). The discussion centered around the keys to success for biotech firms that make the transition from R&D-focused local organizations to global commercial enterprises. This paper provides a concise summary of the discussion.
